Kenneth Reay Code - 30 Jun 2022 Form 4 Insider Report for BIOLARGO, INC. (BLGO)

Reporting relationship: Chief Science Officer, Director
Issuer ticker: BLGO
Reported as of: 30 Jun 2022
Net transaction value: +$19,401
SEC form: 4
Accepted by SEC: 05 Jul 2022, 20:29:51 UTC
Prior SEC filing: 04 Jan 2022
Next SEC filing: 05 Oct 2022
Source filing: View source filing
Reporting owner signature: /s/ John R. Browning, Attorney-in-fact

Key filing fact

Kenneth Reay Code filed Form 4 for BIOLARGO, INC. (BLGO) on 05 Jul 2022.

Key facts

This page summarizes Kenneth Reay Code's Form 4 filing for BIOLARGO, INC. (BLGO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Jul 2022, 20:29.

Change

Previous filing in this sequence was filed on 04 Jan 2022.
Current net transaction value: +$19,401.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BLGO transaction

Common stock

Award

Transaction value: $19,401
Shares: +107,784
Change %: +0.44%
Price: $0.1800
Shares after: 24,703,879
Date: 30 Jun 2022
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares and acquisition price per share).

Footnote F2

Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation.